U.S. Health Care REITs Stock News

AGNC Investment Corp. recently completed a public offering of 12,000,000 depositary shares representing its new 8.75% Series H Fixed-Rate Cumulative Redeemable Preferred Stock at US$25 per share, raising US$300 million in gross proceeds. This preferred equity offering introduces a new callable, cumulative, and perpetual security, potentially influencing AGNC's funding structure and future investment capacity. We'll explore how this substantial preferred stock issuance could impact AGNC's...

GameStop is preparing to report its second-quarter 2025 results on September 9, with discussions growing around the company’s sizable cash reserves and the lack of communication on future investment direction. Investor attention is focused on how CEO Ryan Cohen may shift GameStop into a holding company model and allocate its growing cash pile, particularly given ongoing uncertainty around digital asset strategies. We'll explore how uncertainty surrounding GameStop’s cash deployment plans...

Carrier Global recently appointed Ms. Beril Yildiz as Vice President, Controller, and Chief Accounting Officer, effective September 22, 2025, bringing her experience from International Flavors & Fragrances, Revlon, and Colgate-Palmolive to the role. This move highlights Carrier Global’s focus on reinforcing its financial leadership by drawing on expertise from leaders at global consumer and industrial firms. We will explore how bringing an accomplished financial executive to Carrier Global’s...

In late August 2025, Jacobs Solutions announced several major contract wins including a 15-year renewal for Centennial, Colorado’s public works, a key joint venture on New York’s Interborough Express Light Rail, and a decade-long tunnel project in Denmark. These diverse, long-term awards highlight Jacobs’ strong reputation and trusted partner status in global public infrastructure, from urban modernization in the US to large-scale engineering in Europe. We'll examine how Jacobs’ expanding...

StoneCo recently agreed to pay a settlement to STNE investors, resolving claims that it misled the market about the safety, profitability, and collectability of its merchant credit product between March 2020 and November 2021. This settlement follows revelations that nearly half the loan portfolio was non-performing, raising questions about the company's prior risk management disclosures. We’ll examine how the investor lawsuit settlement over credit product misstatements could influence...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

On August 28, 2025, Dollar General Corporation reported strong second-quarter earnings with net sales of US$10.73 billion and net income of US$411.43 million, while also raising its guidance for full-year net sales growth, same-store sales, and diluted earnings per share. The company’s improved outlook, driven by steady consumer demand and recent operational performance, highlights the ongoing strength of value-focused retailers in serving cost-conscious shoppers, especially in uncertain...

Figma recently released its first earnings report as a public company, revealing second-quarter revenue growth of 41% alongside guidance for a deceleration in sales growth and the expiration of insider lockups. The company also unveiled several new AI-driven products and completed acquisitions, while clarifying that its increased bitcoin holdings remain a small part of its overall treasury strategy. We'll explore how Figma's cautious guidance on future revenue growth sharpens questions about...

Invivyd, Inc. recently announced that the SPEAR Study Group has issued its consensus recommendation on the clinical study design to evaluate the effects of monoclonal antibody therapy, VYD2311, on Long COVID, building on its prior emergency use authorization for related monoclonal antibodies in the U.S. This recommendation highlights growing scientific and medical interest in therapeutic solutions for Long COVID, reflecting Invivyd’s position in addressing emerging and persistent unmet...

Veeva Systems recently reported its second quarter 2025 earnings, revealing year-over-year revenue growth to US$789.08 million and net income of US$200.31 million, alongside updated guidance for the third quarter and full fiscal year. The company’s improved earnings per share and updated revenue outlook reflect continued momentum in cloud-based solutions for life sciences and may reinforce confidence in its longer-term growth prospects. We'll explore how Veeva's stronger-than-expected...

On August 25, 2025, Weyerhaeuser Company and its subsidiary secured US$800 million in senior unsecured term loans, applying about US$500 million to partially redeem existing notes and allocating the remainder for general corporate needs. This refinancing effort, coupled with interest rate swaps to fix the loan rate at 4.31%, may support cost management and financial flexibility through adjusted covenants and improved capital structure. We will now examine how Weyerhaeuser's recent...

Wingstop recently launched its limited-time Smoky Chipotle Rub flavor on September 3, offering fans a new dry rub inspired by smoky BBQ with hints of honey and paprika, alongside a game day promotion of free wings with qualifying orders. This targeted menu innovation, released specifically for football season kickoff, highlights how Wingstop aims to boost customer excitement and traffic during peak demand periods. We'll explore how this menu launch, designed to increase engagement and game...

Recently, Gilead Sciences announced a multi-year partnership with the U.S. State Department and PEPFAR to deliver its twice-yearly HIV prevention therapy, lenacapavir, to up to two million people in PEPFAR- and Global Fund-supported countries, alongside new manufacturing and product expansion efforts. This initiative not only extends the global reach of Gilead’s innovative HIV therapy but also highlights the company’s recognized leadership in HIV philanthropy and advances in biopharma...

In recent months, e.l.f. Beauty attracted significant analyst attention as its rapid international and product line expansion captured industry interest. Analysts and market watchers are closely monitoring the company's overseas growth ambitions and the role of social media sentiment in influencing consumer demand and brand perception. Given heightened scrutiny of e.l.f. Beauty's ambitious expansion plans, we'll explore how this development shapes the company's evolving investment...

In the past week, lululemon athletica released its second quarter results, reporting US$2.53 billion in revenue and adjusted earnings per share that exceeded expectations, but also lowered its full-year guidance due to weak U.S. demand and increased tariffs. Alongside these financial updates, the company announced executive leadership changes and an expanded focus on technology and AI to help reinvigorate growth and address ongoing challenges in its product lineup. We'll now look at how...

International Seaways recently announced a fixed-income offering, initiating investor meetings for a planned five-year US dollar-denominated senior unsecured bond to refinance the Ocean Yield sale-and-leaseback agreement and for general corporate purposes. This move highlights the company’s continued focus on financial flexibility and proactive capital management in a shifting capital markets landscape. We'll explore how this planned bond issue may affect International Seaways' investment...

BridgeBio Pharma recently presented clinical trial updates for acoramidis in transthyretin amyloid cardiomyopathy (ATTR-CM) at the European Society of Cardiology Congress 2025, including new data on reduced cardiovascular mortality and sustained clinical benefits from its open-label extension study. These disclosures are significant because they showcase pivotal results for the company’s lead drug candidate, which could influence broad perceptions among healthcare professionals and investors...

Earlier this week, a US judge dismissed Eli Lilly's lawsuit against Willow Health and other telehealth firms over compounded weight-loss drug sales, easing legal uncertainties for peers like Hims & Hers Health, which was not a defendant in the case. This legal development comes shortly after Novo Nordisk ended its partnership with Hims & Hers amid allegations regarding compounded drug compliance, positioning this judgment as a pivotal moment for the industry. We'll now assess how the...

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...

Earlier this week, Lumentum Holdings Inc. completed a US$1.1 billion convertible senior note offering due March 15, 2032, featuring a 0.375% fixed coupon and unsecured senior status under Rule 144A. This capital raise could enhance Lumentum's financial flexibility and fund future growth or investment opportunities as the company addresses expanding optical and photonic markets. We'll examine how this sizable convertible note issuance may influence Lumentum's investment narrative and capital...

Endava ( NYSE:DAVA ) Full Year 2025 Results Key Financial Results Revenue: UK£772.3m (up 4.3% from FY 2024). Net...

U.S. crude oil production reached a record 13.58 million barrels per day in June, largely driven by output gains in Texas, New Mexico, and the Gulf region. This surge in production supports operators like Chord Energy, which benefit from efficiency improvements and increased activity across major shale basins. We'll explore how record U.S. oil production strengthens Chord Energy's investment narrative, particularly regarding operational efficiencies and market outlook. We've found 18 US...

Shares of general merchandise retailer Target experienced a sharp decline after a federal court ruling challenged the legality of global tariffs, leading to profit-taking and increased market uncertainty. This event coincided with mixed second quarter results, including a slight miss on gross margin, reduced store traffic, and news of a CEO transition, adding to investor unease. We'll examine how concerns around trade policy uncertainty and softer store performance could influence Target's...

Equinix has reached a final settlement agreement with investors regarding a class action lawsuit, following allegations from Hindenburg Research that the company overstated its Adjusted Funds From Operations by at least 22% in 2023; the settlement is now pending final court approval. This settlement highlights significant concerns around Equinix's financial reporting practices and brings renewed focus to the company's approach to corporate governance and transparency. We'll explore how the...